| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,550 | 18,629 | 20,141 | 15,434 | | Cost of Revenue | 12,130 | 11,598 | 12,768 | 11,093 | | | Gross Profit | 7,420 | 7,031 | 7,373 | 4,341 | | | Operating Expenses | | Research Development | 457 | 405 | 446 | 489 | | Selling General and Administrative | 5,804 | 5,616 | 5,910 | 5,777 | | Non Recurring |
-
|
-
|
-
| 1,017 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,159 | 1,010 | 1,017 | (2,942) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 26 | (26) | (16) | | Earnings Before Interest And Taxes | 1,159 | 1,036 | 991 | (2,958) | | Interest Expense | (13) | 67 | 139 | 124 | | Income Before Tax | 1,172 | 969 | 852 | (3,082) | | Income Tax Expense | 429 | 390 | 392 | (1,215) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 743 | 579 | 460 | (1,867) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 743 | 579 | 460 | (1,867) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $743 | $579 | $460 | ($1,867) |
|
0.22% Nasdaq 
0.01 (3.23%) 
Income Statement
